secwatch.observer — SEC 8-K summary
======================================

Issuer:     RECURSION PHARMACEUTICALS, INC. (RXRX)
CIK:        0001601830
Form:       8-K
Filed at:   2025-05-09T23:59:59+00:00
Accession:  0001193125-25-116989
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Recursion registers 4.26M shares for resale by Tempus Labs under prior license agreement
--------------------------------------------------------------------------------

- Filed prospectus supplement to register 4,260,927 shares of Class A common stock for resale by Tempus Labs, Inc.
- Shares were issued as payment for annual license fees under a Master Agreement dated Nov 2023.
- Offering made under an exemption from registration; legal opinion filed as Exhibit 5.1.
- Registration does not involve new issuance of shares; existing shares held by Tempus.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601830/000119312525116989/0001193125-25-116989-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601830/000119312525116989/d947576d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-116989

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer